MedMen Bails Out Beleaguered Bloomfield Industries, Buys New York Medical Cannabis Company


Politico followed up with its earlier article about a possible bailout of Bloomfield Industries that we covered previously by breaking the news that the company has sold itself to MedMen, the California cannabis consultant that recently established an investment fund. Interestingly, financial backer Wicklow Capital is also an investor in PharmaCann, which holds one of the four other licenses in the state. New York rules prohibit license transfer, but the state approved the acquisition. MedMen will be required to maintain the Bloomfield name and stick to the original operating plan through July 31.

Bloomfield struggled more than its rivals as the highly restrictive nature of New York’s program limited the pool of potential patients. Recent moves to broaden qualifying conditions, including the addition of chronic pain should help the industry, but the state is in the process of adding five additional providers. The Politico article details some of the particular challenges that impacted Bloomfield Industries. No financial details were available, and Politico was unable to get comments from either Bloomfield Industries or MedMen.

Read Dan Goldberg’s “California firm acquiring Bloomfield Industries in medical marijuana shakeup”:

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter